Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8349574 Methods of determining patient response by measurement of Her-3

Patent 8349574 was granted and assigned to LABORATORY CORPORATION OF AMERICA HOLDINGS on January, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

LABORATORY CORPORATION OF AMERICA HOLDINGS

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8349574

Date of Patent

January 8, 2013

Patent Application Number

12688798

Date Filed

January 15, 2010

Patent Citations Received

‌

US Patent 11939394 Binding molecules that inhibit cancer growth

‌

US Patent 11708602 Simultaneous quantification of gene expression in a user-defined region of a cross-sectioned tissue

‌

US Patent 11773170 Antibodies that bind EGFR and cMET

‌

US Patent 11780925 ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene

Patent Primary Examiner

‌

Anne M. Gussow

Patent abstract

The invention provides methods of measuring and/or quantifying the presence and/or amount of Her-3 and/or Her-3 in a complex in a sample. The invention also provides antibodies specific for Her-3.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8349574 Methods of determining patient response by measurement of Her-3

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API